Combinations and methods of using an immunomodulatory oligodeoxynucleotide

Details for Australian Patent Application No. 2006315632 (hide)

Owner Pfizer, Inc.

Inventors Jungnelius, Jarl Ulf Birger; Readett, David Robert John; Denis, Louis J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006315632

PCT Pub. Number WO2007/059041

Priority 60/735,351 11.11.05 US; 60/736,527 14.11.05 US

Filing date 13 November 2006

Wipo publication date 24 May 2007

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/059041 Priority application(s): WO2007/059041

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315638-Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements

2006315629-Deposition of discrete nanoparticles on an implant surface